Argos Therapeutics, Inc. Twitter Community Guidelines
Our Twitter handle, @ArgosThera, provides an exciting opportunity to connect and interact with individuals and organizations interested in our company. We intend to use Twitter to share company news and announcements, provide corporate information and live updates from trade show presentations and medical conferences, and participate in important community outreach and disease awareness efforts.
It is our goal to interact with as many Twitter users as possible when appropriate, but please note we may not be able to reply individually to all messages received via @ArgosThera. Tweets from members of the public do not necessarily reflect the views of Argos Therapeutics and we reserve the right to block or mute users posting inappropriate or offensive material at our sole discretion, with or without notice. If we choose to follow a Twitter account, or a user follows @ArgosThera, this action is not an endorsement of the content those users post independently.
Because we work in a highly regulated healthcare industry we may often be unable to engage in some discussions about products or therapeutic options and will not offer medical advice using the @ArgosThera Twitter handle. If you have a question or comment related to our products, email us at [email protected] or call (919) 287-6300.
If you believe you have experienced an adverse event or side effect related to an Argos Therapeutics product, please contact your healthcare provider immediately. You can also visit the FDA safety information and adverse reporting program online. If you are participating in a clinical study, please report adverse events as required in the study protocol. If you post a direct Tweet at @ArgosThera with information about an adverse event or side effect, please note we may be required to contact you for additional information to comply with regulatory guidelines.